Mitch McGill, Ph.D., Is Part of Research Group Examining Liver Safety Biomarker (opens in new tab)

Mitch McGill, Ph.D., faculty at the University of Arkansas for Medical Sciences (UAMS), is part of a nationwide collaboration that recently succeeded in obtaining FDA acceptance of a new biomarker, dehydrogenase (GLDH) biomarker. Glutamate dehydrogenase is an enzyme located primarily in the liver. According to the United States Food and Drug Administration (FDA), a biomarker...